Home
>
National Drug Code (NDC)
>
Vyvanse
Vyvanse - 59417-103-10 - (lisdexamfetamine dimesylate)
Drug Information of Vyvanse
| Product NDC: | 59417-103 |
| Proprietary Name: | Vyvanse |
| Non Proprietary Name: | lisdexamfetamine dimesylate |
| Active Ingredient(s): | 30 mg/1 & nbsp; lisdexamfetamine dimesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vyvanse
| Product NDC: | 59417-103 |
| Labeler Name: | Shire LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021977 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070223 |
Package Information of Vyvanse
| Package NDC: | 59417-103-10 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (59417-103-10) |
NDC Information of Vyvanse
| NDC Code | 59417-103-10 |
| Proprietary Name | Vyvanse |
| Package Description | 100 CAPSULE in 1 BOTTLE (59417-103-10) |
| Product NDC | 59417-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lisdexamfetamine dimesylate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070223 |
| Marketing Category Name | NDA |
| Labeler Name | Shire LLC |
| Substance Name | LISDEXAMFETAMINE DIMESYLATE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
